Last reviewed · How we verify
Refractory Aspergillosis
Approved treatments
- Cancidas · Merck & Co.
Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall. - Abelcet · Astellas Pharma
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Refractory Aspergillosis patent landscape — cliff calendar, originator estates, attackable patents
- Refractory Aspergillosis treatment landscape brief
- Refractory Aspergillosis treatment updates RSS
Frequently asked questions about Refractory Aspergillosis
What drugs treat Refractory Aspergillosis?
Tracked treatments include Cancidas, Abelcet.
What is the treatment for Refractory Aspergillosis?
Standard treatment for Refractory Aspergillosis includes Cancidas, Abelcet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Refractory Aspergillosis patent cliff · Refractory Aspergillosis CI report
- Treatment: Cancidas · Merck & Co.
- Treatment: Abelcet · Astellas Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing